Precise targeting of the globus pallidus internus with quantitative susceptibility mapping for deep brain stimulation surgery.

Related Articles:

• Combining quantitative susceptibility mapping to the morphometric index in differentiating between progressive supranuclear palsy and Parkinson's disease. October 22, 2019 Combining quantitative susceptibility mapping to the morphometric index in differentiating between progressive supranuclear palsy and Parkinson's disease. J Neurol Sci. 2019 Aug 31;406:116443 Authors: Azuma M, Hirai T, Nakaura T, Kitajima M, Yamashita S, Hashimoto M, Yamada K, Uetani H, Yamashita Y, Wang Y Abstract PURPOSE: To determine whether the susceptibility value in the deep gray matter obtained by quantitative…
• Evaluation of iron deposition in brain basal ganglia of patients with Parkinson's disease using quantitative susceptibility mapping. May 9, 2019 Related ArticlesEvaluation of iron deposition in brain basal ganglia of patients with Parkinson's disease using quantitative susceptibility mapping. Eur J Radiol Open. 2019;6:169-174 Authors: Shahmaei V, Faeghi F, Mohammdbeigi A, Hashemi H, Ashrafi F Abstract Aim of the study: Parkinson's disease is associated with iron deposition in the brain. The QSM (quantitative susceptibility mapping) is more sensitive than T2-weighted imaging,…
• Letter: Commentary: Utilization of Quantitative Susceptibility Mapping for Direct Targeting of the Subthalamic Nucleus During Deep Brain Stimulation Surgery. August 28, 2019 Related ArticlesLetter: Commentary: Utilization of Quantitative Susceptibility Mapping for Direct Targeting of the Subthalamic Nucleus During Deep Brain Stimulation Surgery. Oper Neurosurg (Hagerstown). 2018 10 01;15(4):44 Authors: Kopell BH, Dimov A, Rasouli J, Wang Y PMID: 30010991 [PubMed - indexed for MEDLINE]
• Commentary: Utilization of Quantitative Susceptibility Mapping for Direct Targeting of the Subthalamic Nucleus During Deep Brain Stimulation Surgery. August 16, 2019 Related ArticlesCommentary: Utilization of Quantitative Susceptibility Mapping for Direct Targeting of the Subthalamic Nucleus During Deep Brain Stimulation Surgery. Oper Neurosurg (Hagerstown). 2018 04 01;14(4):420-421 Authors: Alterman RL PMID: 28633383 [PubMed - indexed for MEDLINE]
• Strategically acquired gradient echo (STAGE) imaging, part III: Technical advances and clinical applications of a rapid multi-contrast multi-parametric brain imaging method. October 20, 2019 Strategically acquired gradient echo (STAGE) imaging, part III: Technical advances and clinical applications of a rapid multi-contrast multi-parametric brain imaging method. Magn Reson Imaging. 2019 Oct 16;: Authors: Haacke EM, Chen Y, Utriainen D, Wu B, Wang Y, Xia S, He N, Zhang C, Wang X, Lagana MM, Luo Y, Fatemi A, Liu S, Gharabaghi S, Wu D, Sethi SK,…
• In Reply: Commentary: Utilization of Quantitative Susceptibility Mapping for Direct Targeting of the Subthalamic Nucleus During Deep Brain Stimulation Surgery. August 28, 2019 Related ArticlesIn Reply: Commentary: Utilization of Quantitative Susceptibility Mapping for Direct Targeting of the Subthalamic Nucleus During Deep Brain Stimulation Surgery. Oper Neurosurg (Hagerstown). 2018 10 01;15(4):45 Authors: Alterman RL, Fleishman A, Ngo L PMID: 30011048 [PubMed - indexed for MEDLINE]
• Globus pallidus internus deep brain stimulation induces tremor in Parkinson's disease: A paradoxical phenomenon. July 24, 2018 Globus pallidus internus deep brain stimulation induces tremor in Parkinson's disease: A paradoxical phenomenon. J Neurol Sci. 2018 Jul 10;392:102-104 Authors: Hu W, Eisinger R, Hess C, Foote K, Okun M, Wagle Shukla A PMID: 30036780 [PubMed - as supplied by publisher]
• Globus pallidus internus deep brain stimulation in PINK-1 related Parkinson's disease: A case report. February 27, 2017 Globus pallidus internus deep brain stimulation in PINK-1 related Parkinson's disease: A case report. Parkinsonism Relat Disord. 2017 Feb 20;: Authors: Borellini L, Cogiamanian F, Carrabba G, Locatelli M, Rampini P, Di Fonzo A, Bana C, Barbieri S, Ardolino G PMID: 28237855 [PubMed - as supplied by publisher]
• Iron deposition in Parkinson's disease by quantitative susceptibility mapping. May 24, 2019 Related ArticlesIron deposition in Parkinson's disease by quantitative susceptibility mapping. BMC Neurosci. 2019 May 22;20(1):23 Authors: Chen Q, Chen Y, Zhang Y, Wang F, Yu H, Zhang C, Jiang Z, Luo W Abstract BACKGROUND: Patients with Parkinson's disease (PD) have elevated levels of brain iron, especially in the nigrostriatal dopaminergic system. The purpose of this study was to evaluate the…
• Voxel-based quantitative susceptibility mapping in Parkinson's disease with mild cognitive impairment. May 16, 2019 Voxel-based quantitative susceptibility mapping in Parkinson's disease with mild cognitive impairment. Mov Disord. 2019 May 15;: Authors: Uchida Y, Kan H, Sakurai K, Arai N, Kato D, Kawashima S, Ueki Y, Matsukawa N Abstract OBJECTIVE: Brain iron accumulation has been proposed as one of the pathomechanisms in Parkinson's disease (PD). This study aimed to examine the whole-brain pattern of iron…
• Deep Learning-Based Deep Brain Stimulation Targeting and Clinical Applications. November 12, 2019 Related ArticlesDeep Learning-Based Deep Brain Stimulation Targeting and Clinical Applications. Front Neurosci. 2019;13:1128 Authors: Park SC, Cha JH, Lee S, Jang W, Lee CS, Lee JK Abstract Background: The purpose of the present study was to evaluate deep learning-based image-guided surgical planning for deep brain stimulation (DBS). We developed deep learning semantic segmentation-based DBS targeting and prospectively applied the method…
• Long-term Outcome of Globus Pallidus Internus Stimulation for Pisa Syndrome. March 21, 2019 Related ArticlesLong-term Outcome of Globus Pallidus Internus Stimulation for Pisa Syndrome. Cureus. 2019 Jan 07;11(1):e3838 Authors: Anderson BL, Ziechmann R, Huang X, McInerney J Abstract Pisa syndrome, defined as dystonia leading to lateral flexion of the spine, is an increasingly recognized complicating factor in the treatment of Parkinson's disease (PD). Symptoms may persist despite medical therapy, or medical therapy may…
• Gender Disparities in Deep Brain Stimulation for Parkinson's Disease. May 24, 2019 Gender Disparities in Deep Brain Stimulation for Parkinson's Disease. Neuromodulation. 2019 May 23;: Authors: Shpiner DS, Di Luca DG, Cajigas I, Diaz JS, Margolesky J, Moore H, Levin BE, Singer C, Jagid J, Luca CC Abstract OBJECTIVES: This study sought to determine whether there is a gender disparity in patients undergoing deep brain stimulation (DBS) surgery for Parkinson's disease (PD)…
• Mood Effects After Deep Brain Stimulation for Parkinson's Disease: An Update. July 2, 2019 Mood Effects After Deep Brain Stimulation for Parkinson's Disease: An Update. Front Neurol. 2019;10:617 Authors: Accolla EA, Pollo C Abstract Depression in Parkinson's Disease (PD) is a prevalent and invalidating symptom. Deep brain stimulation (DBS) allows for an improvement of PD motor features, but its effects on mood are difficult to predict. Here, we review the evidence regarding mood effects…
• Electrophysiologic mapping for deep brain stimulation for movement disorders. July 7, 2019 Related ArticlesElectrophysiologic mapping for deep brain stimulation for movement disorders. Handb Clin Neurol. 2019;160:345-355 Authors: Campbell BA, Machado AG, Baker KB Abstract Electrophysiologic mapping remains an integral component of deep brain stimulation (DBS) surgical procedures, particularly in movement disorder cases where functional maps are used to guide DBS lead placement in patients with Parkinson's disease, dystonia, or tremor. Overall, the…
• Mapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism. April 17, 2019 Related ArticlesMapping of apparent susceptibility yields promising diagnostic separation of progressive supranuclear palsy from other causes of parkinsonism. Sci Rep. 2019 Apr 15;9(1):6079 Authors: Sjöström H, Surova Y, Nilsson M, Granberg T, Westman E, van Westen D, Svenningsson P, Hansson O Abstract There is a need for methods that distinguish Parkinson's disease (PD) from progressive supranuclear palsy (PSP) and multiple…
• Potential usefulness of signal intensity of cerebral gyri on quantitative susceptibility mapping for discriminating corticobasal degeneration from progressive supranuclear palsy and Parkinson's disease. July 4, 2019 Related ArticlesPotential usefulness of signal intensity of cerebral gyri on quantitative susceptibility mapping for discriminating corticobasal degeneration from progressive supranuclear palsy and Parkinson's disease. Neuroradiology. 2019 Jul 02;: Authors: Miyata M, Kakeda S, Toyoshima Y, Ide S, Okada K, Adachi H, Wang Y, Korogi Y Abstract PURPOSE: The typical MRI findings in corticobasal degeneration (CBD), which have been described in…
• Globus Pallidus Externus Deep Brain Stimulation Treats Insomnia in a Patient With Parkinson Disease February 1, 2020 Sleep disorders are the second most common complaint in patients with Parkinson disease (PD), affecting up to 78.3% of patients and having severe impact on quality of life. Many patients fail hypnotic therapy or cognitive behavioral therapy for insomnia. In addition, many pharmacological treatments carry added risks in patients with PD (eg, increased risk of falls). The majority of existing…
• Quantitative susceptibility mapping in atypical Parkinsonisms. September 21, 2019 Quantitative susceptibility mapping in atypical Parkinsonisms. Neuroimage Clin. 2019 Aug 31;24:101999 Authors: Mazzucchi S, Frosini D, Costagli M, Del Prete E, Donatelli G, Cecchi P, Migaleddu G, Bonuccelli U, Ceravolo R, Cosottini M Abstract BACKGROUND AND PURPOSE: Differential diagnosis between Parkinson's disease (PD) and Atypical Parkinsonisms, mainly Progressive Supranuclear Palsy (PSP) and Multiple System Atrophy (MSA), remains challenging. The low…
• Quantitative magnetization transfer imaging of the human locus coeruleus. June 25, 2019 Quantitative magnetization transfer imaging of the human locus coeruleus. Neuroimage. 2019 Jun 21;: Authors: Trujillo P, Petersen KJ, Cronin MJ, Lin YC, Kang H, Donahue MJ, Smith SA, Claassena DO Abstract The locus coeruleus (LC) is the major origin of norepinephrine in the central nervous system, and is subject to age-related and neurodegenerative changes, especially in disorders such as Parkinson's…